Obesity and obstructive sleep apnea‐hypopnea syndrome
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Summary: Obstructive sleep apnea‐hypopnea syndrome involves recurring episodes of total obstruction (apnea) or partial obstruction (hypopnea) of airways during sleep. Obstructive sleep apnea‐hypopnea syndrome affects mainly obese individuals and it is defined by an apnea‐hypopnea index of five or more episodes per hour associated with daytime somnolence. In addition to anatomical factors and neuromuscular and genetic factors, sleep disorders are also involved in the pathogenesis of sleep apnea. Obesity affects upper airway anatomy because of fat deposition and metabolic activity of adipose tissue. Obstructive sleep apnea‐hypopnea syndrome and metabolic syndrome have several characteristics such as visceral obesity, hypertension and insulin resistance. Inflammatory cytokines might be related to the pathogenesis of sleep apnea and metabolic syndrome. Sleep apnea treatment includes obesity treatment, use of equipment such as continuous positive airway pressure, drug therapy and surgical procedures in selected patients. Currently, there is no specific drug therapy available with proven efficacy for the treatment of obstructive sleep apnea‐hypopnea syndrome. Body‐weight reduction results in improvement of sleep apnea, and obesity treatment must be emphasized, including lifestyle changes, anti‐obesity drugs and bariatric surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of the obese Gene Product on Body Weight Regulation in ob / ob Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017
Obstructive Sleep Apnea as a Risk Factor for Stroke and Death
Yaggi, H. K., Concato, J., Kernan, W. N., Lichtman, J. H., Brass, L. M., & Mohsenin, V. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043104 · Cited by 3,004 · cited 1×
“carried out a prospective study on 697 individuals with severe OSAHS (average AHI 35) and observed that this population has been a twofold risk for stroke and death, even after adjustment for other cardiovascular risk factors (103).”
Sleep-disordered Breathing and Cardiovascular Disease
SHAHAR, E., WHITNEY, C. W., REDLINE, S., LEE, E. T., NEWMAN, A. B., JAVIER NIETO, F., O'CONNOR, G. T., BOLAND, L. L., SCHWARTZ, J. E., & SAMET, J. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.2001008 · Cited by 2,901
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdán, M. G., Diano, S., Horvath, T. L., Cone, R. D., & Low, M. J. (2001) · Nature · doi:10.1038/35078085 · Cited by 2,356
Longitudinal Study of Moderate Weight Change and Sleep-Disordered Breathing
Peppard, P. E. (2000) · JAMA · doi:10.1001/jama.284.23.3015 · Cited by 2,020
Strollo, P. J., & Rogers, R. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601113340207 · Cited by 1,313
Day–Night Pattern of Sudden Death in Obstructive Sleep Apnea
Gami, A. S., Howard, D. E., Olson, E. J., & Somers, V. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041832 · Cited by 1,032 · cited 1×
“Additionally, prevalence of sudden death from cardiovascular causes during midnight is significantly higher among OSAHS patients as compared with non-apneic controls, who, in contrast, exhibit a nadir of prevalence for sudden death in midnight (104).”
Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation
Kanagala, R., Murali, N. S., Friedman, P. A., Ammash, N. M., Gersh, B. J., Ballman, K. V., M. Shamsuzzaman, A. S., & Somers, V. K. (2003) · Circulation · doi:10.1161/01.cir.0000068337.25994.21 · Cited by 983 · cited 1×
“Additionally, patients with non-treated OSAHS have a twofold risk of atrial fibrillation when compared with patients under proper therapeutics (97).”
Jenkinson, C., Davies, R. J., Mullins, R., & Stradling, J. R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10532-9 · Cited by 826
Cited by
Circadian Rhythms and Metabolic Syndrome: From Experimental Genetics to Human Disease
Maury, E., Ramsey, K. M., & Bass, J. (2010) · Circulation Research · doi:10.1161/circresaha.109.208355 · Cited by 500
Johansson, K., Neovius, M., Lagerros, Y. T., Harlid, R., Rossner, S., Granath, F., & Hemmingsson, E. (2009) · BMJ · doi:10.1136/bmj.b4609 · Cited by 227
Lam, J. C. M., Lam, B., Yao, T. J., Lai, A. Y. K., Ooi, C. G., Tam, S., Lam, K. S. L., & Ip, M. S. M. (2010) · European Respiratory Journal · doi:10.1183/09031936.00047709 · Cited by 170
Fernandez, R., Moore, V., Van Ryswyk, E., Varcoe, T., Rodgers, R., March, W., Moran, L., Avery, J., McEvoy, D., & Davies, M. (2018) · Nature and Science of Sleep · doi:10.2147/nss.s127475 · Cited by 137
Cercato, C., Roizenblatt, V. A., Leança, C. C., Segal, A., Lopes Filho, A. P., Mancini, M. C., & Halpern, A. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.124 · Cited by 100
Self-citation
Metadata
- Authors
- De Sousa, A. G. P., Cercato, C., Mancini, M. C., & Halpern, A.
- Venue
- Obesity Reviews
- Publisher
- Wiley
- Published
- 2008-03-18
- Volume
- 9
- Issue
- 4
- Pages
- 340-354
- ISSN
- 1467-7881 (ISSN-L)
- 1467-789X
- OpenAlex
- W2059243345
- Cited by
- 103
- References
- 32
- FWCI
- 5.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Obesity and obstructive sleep apnea‐hypopnea syndrome. https://app.cochat.ai/papers/10.1111/j.1467-789x.2008.00478.x
- The paper
- De Sousa, A. G. P., Cercato, C., Mancini, M. C., & Halpern, A. (2008). Obesity and obstructive sleep apnea‐hypopnea syndrome. Obesity Reviews. https://doi.org/10.1111/j.1467-789x.2008.00478.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.